Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

COVID-19 Lockdown Exit Analysis

Therapeutic advances in COVID-19

Medsafe blocks sales of COVID-19 'treatment' Artemisia annua extract

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Muscular Dystrophy Association Celebrates FDA Approval of Skyclarys, First Ever Treatment for Friedreich's Ataxia from Reata Pharmaceuticals

Challenges in Sedation Management in Critically Ill Patients with COVID-19: a Brief Review

Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study) - Lynch - 2021 - Annals of Neurology - Wiley Online Library

Artemisia herbal tea, Infusion for symptoms related to covid 19, malaria and painful periods in women., Use: A pinch of dried leaves in a liter of

Artemisia leaves

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective